A class action lawsuit accuses banks of conspiring to limit competition in the $320 trillion market for interest rate swaps.» Read More
The Travelers Cos. on Tuesday reported third-quarter earnings of $919 million.
Hedge funds designed to profit from choppy and down markets have mostly underwhelmed in October.
Some of the names on the move ahead of the open.
Asked if he'd want his old job back, Mohamed El-Erian tells CNBC: "No, I'm really happy with my life."
The Bank of England has launched a "thorough" and "independent" investigation into what caused a 10-hour crash of the U.K.'s interbank payment system Monday which halted high value payments such as house purchases.
After Cramer called bottom on Friday, investors are circling back to Apple and leaving IBM behind. Cramer also picks his winners for the long run.
China's third quarter gross domestic product report delivered an upside surprise, helping calm investor nerves over the faltering global recovery.
United Technologies posted a rise in quarterly profit, helped by a tax settlement and earnings increases across its aerospace and commercial building segments.
AbbVie is walking away from its proposed $55 billion takeover bid of Shire and has agreed to pay the rival drugmaker a $1.64 billion breakup fee.
Lew said recent movements of the euro versus the dollar seem linked more to differences in growth than policies aimed at depreciating the Euro.
When the bond-fund heavyweight Pimco scuffles with passive investing guru John Bogle, it's like watching a good prize-fight boxing match.
JPMorgan Private Bank used the recent market dips to add to its position, the bank's chief investment officer told CNBC Monday.
Art Cashin of UBS Financial Services says markets are trying to decide if IBM's earnings miss is an omen for earnings season or an isolated case.
Pimco need only look at its own performance for a lesson in the perils of active management, Fidelity founder Bogle said.
The market is much calmer this week amid expectations of a more dovish Fed, stabilization in oil prices and easing Ebola concerns.
Valeant Pharmaceuticals said it may raise its bid for Allergan after posting a better-than-expected quarterly profit.
Weakness in Europe has been the dominant driver behind the recent volatility in U.S. stock markets, Mary Callahan Erdoes said.
As Doug Kass sees it, "IBM" just as easily could stand for "I need Buffett's Money."
Reflecting downgrades to the European economic outlook, the bank doesn't expect the yield to rise to 3 percent until the end of next year.
Warren Buffett does not like to lose money in general, so losing $1 billion before lunch on a Monday morning can not be going down well.